Alzheimer's

Antibody staining experiment shows tau RNA complexes that have been stained green.
February 6, 2023

Overlooked tau-RNA interaction plays key role in dementia

RNA contact with tau protein spurs neurofibrillary tangles in the brain — a defining hallmark of Alzheimer’s and other diseases.

Read more
Art activity at UW Medicine Memory Hub
January 9, 2023

Memory Hub now welcomes visitors during public hours

A variety of resources and enjoyable activities are offered for people with memory loss, their caregivers and families.

Read more
micrograph of defective, tangled tau proteins that cause neurons to die
December 26, 2022

Targeting tau, the other protein behind Alzheimer’s disease

Most Alzheimer’s drugs in development target beta-amyloid, but targeting another protein, called tau, may be needed. 

Read more
Patients in need of cataract surgery also see their risk for developing dementia drop by 30% after undergoing the operation, according to new research published today in JAMA Internal Medicine.
December 6, 2021

Dementia risk drops for cataract surgery patients

Patients in need of cataract surgery also see their risk for developing dementia drop by 30% after undergoing the operation, according to new research published today in JAMA Internal Medicine.

man getting an eye exam
December 6, 2021

Study: Cataract surgery linked with lessened dementia risk

Results reported in JAMA Internal Medicine associate cataract surgery with 30% lower risk of dementia in aging population.

Read more
hand holding up cut out of a persons head imposed over a crowd
November 12, 2021

Roundup of 3 recent studies on dementia risk

Researchers examine links to cognitive decline of hearing loss, military service, and timeliness of diagnosis.

Read more
Photo illustration of doctor holding brain
August 26, 2021

$56 million NIH grant to expand Alzheimer’s research

The University of Washington, Kaiser Permanente, and UC San Diego will jointly lead the next phase of an aging-brain study.

Read more
woman sitting in chair with notepad
June 9, 2021

New Alzheimer’s drug said to be 'huge step forward'

UW Medicine was one of the clinical trial sites for aducanumab, a drug approved yesterday by the Food and Drug Administration to slow the progression of Alzheimer’s disease in people with mild symptoms.

imaging scans of a human brain
June 1, 2021

Garvey Institute gives $1.3 million to advance brain health

Second round of funding focuses on technology-driven solutions to relieve burdens of cognitive aging, trauma and addiction.

Read more
Julia Robbins research scientist proteomics research MacCoss lab
October 28, 2020

Brain and spine fluid proteomics may hold Alzheimer’s clues

Research program analyzes cerebrospinal fluid molecules to seek diagnostic and progression markers as well as treatment targets.

Read more

Pages

Subscribe to Alzheimer's